Evidence map›Paper›PMID 39174715›Full record

ArticleZeitschrift fur Rheumatologie2025

Vaccination status of patients with primary immunodeficiencies in Germany-a multicentric epidemiologic analysis.

Eva C Schwaneck, Anna S Harasim, Hans-Peter Tony, Micha Gawlik, Torsten Witte, Stefanie Joos, Michael Gernert, Marc Schmalzing, Henner Morbach, Matthias Fröhlich and 1 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Zeitschrift fur Rheumatologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Eva C SchwaneckDivision of Rheumatology/Immunology, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany. e.schwaneck@rheuma-hh.de.ORCID http://orcid.org/0000-0003-1935-2092
Anna S HarasimDivision of Rheumatology/Immunology, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany.ORCID http://orcid.org/0000-0002-2866-9481
Hans-Peter TonyDivision of Rheumatology/Immunology, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany.
Micha GawlikDepartment of Psychiatry and Psychotherapy, University of Würzburg, Margarete-Höppel-Platz 1, 97080, Würzburg, Germany.
Torsten WitteDepartment of Rheumatology and Clinical Immunology, Hanover Medical School, Carl-Neuberg-Straße 1, 30625, Hanover, Germany.ORCID http://orcid.org/0000-0003-4531-0267
Stefanie JoosInstitute for General Practice and Interprofessional Healthcare, Eberhardt-Karls-University, Osianderstraße 5, 72076, Tübingen, Germany.ORCID http://orcid.org/0000-0002-5810-529X
Michael GernertDivision of Rheumatology/Immunology, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany.ORCID http://orcid.org/0000-0003-0074-4459
Marc SchmalzingDivision of Rheumatology/Immunology, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany.
Henner MorbachPediatric Immunology, Department of Pediatrics, University Hospital Würzburg, Josef-Schneider-Straße 2, 97080, Würzburg, Germany.ORCID http://orcid.org/0000-0002-5819-726X
Matthias FröhlichDivision of Rheumatology/Immunology, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany.ORCID http://orcid.org/0000-0001-7745-3903
Manuel KroneInstitute for Hygiene and Microbiology, University of Würzburg, Josef-Schneider-Straße 2/E1, 97080, Würzburg, Germany.ORCID http://orcid.org/0000-0002-1020-6454

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVaccinations represent an easily accessible, safe, and important method for preventing infections. Patients with primary immunodeficiencies (PID) are more susceptible to infections and should receive an extended spectrum of immunizations in many countries.

methodsBetween January 2019 and May 2020, vaccination certificates of 70 patients with PID from the regions of Würzburg and Hanover in Germany were evaluated. The patients were additionally surveyed regarding their attitude towards vaccinations and the communication with their physicians. Medical records were analyzed.

resultsOf the 70 patients, 54 (77%) suffered from common variable immunodeficiency, 30 (43%) were diagnosed with accompanying autoimmunity, 62 (89%) had an increased susceptibility to infections, and 56 (80%) were on immunoglobulin substitution therapy. Seven patients (10%) had neither a vaccination certificate nor were they able to recollect of their last vaccination. Only 55 (79%) and 43 (61%) patients stated that their rheumatologist or immunologist had recommended an influenza and a pneumococcal vaccination, respectively. When asked about their overall trust in vaccinations on a scale of 0 to 10 (0 = very low, 10 = very high), the mean value was 7.8. The most common vaccination was against tetanus in 63 (90%) patients, 49 (70%) had received vaccination against pneumococci, and 39 (56%) had received an influenza vaccination. Interestingly, 26 patients (37%) were vaccinated against measles, even though this is contraindicated in most PID patients.

conclusionOur data suggest that vaccination rates in this at-risk population are insufficient. Healthcare providers should emphasize vaccinations routinely when caring for these patients.

Indexed as

Immunologic Deficiency SyndromesPrimary Immunodeficiency DiseasesVaccinationVaccination CoverageAdolescentAdultAgedChildChild, PreschoolFemaleGermanyHumansMaleMiddle AgedProspective StudiesYoung AdultAntibody deficiencyCommon variable immunodeficiencyPrimary immunodeficienciesVaccines

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.